Prostate cancer (PCa) is the most common cancer in men in western countries and is the second leading cause of cancer death in men 1, 2 , second only to lung cancer. Androgen deprivation therapy is an important method for the clinical treatment of human prostate cancer. However the transformation of androgen-dependent human prostate cancer cells into androgen-independent manner during androgen deprivation therapy is the main obstacle that impacts the treatment. Growing evidence has proved that mesenchymal stem cells (MSCs) may play an important role in the development of prostate cancer 3, 4 . However, the role of mesenchymal stem cells in the transformation of androgen-dependent human prostate cancer cells into androgen-independent manner is still not fully understood.
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MSCs originating from the mesodermal germ layer are a subset of nonhematopoietic stem cells existed in bone marrow 5, 6 . MSCs were described as an adherent, fibroblast-like population and have the ability to differentiate into multiple lineages such as chondrocytes, osteocytes, adipocytes, myocytes, and astrocytes, which is a potential source of stem cells for cellular and genetic therapy 7, 8 . MSCs also existed in other tissues, including adipose, umbilical cord, muscle, lung and fetal liver 7, [9] [10] [11] [12] . MSCs have a tropism for tumors 13 and several studies have reported contradictory results about the effect of MSCs on tumor growth. Hall et al. 14 demonstrated that co-culture of ALL cell lines with stromal cells which is overexpressed of VCAM-1 enhanced the survival of leukemic cells in a PI-3 kinase dependent manner compared to the co-culture with stromal cells expressing only endogenous VCAM-1. Djouad et al. 15 showed that MSCs had displayed side effects related to systemic immunosupression favoring tumor growth in vivo. On the contrary, MSCs have been reported to be anti-tumorigenic in a mouse model of Kaposi's sarcoma by inhibiting AKT activity 16 . The stroma tissue is an important part of tumor and MSCs is the progenitor cells of stromal cells. So we suppose that MSCs may play a key role in inducing androgen resistance in human prostate cancer cells. In this study, we used LNCaP prostate cancer cell line to investigate the effect of MSCs on the transformation of androgen-dependent human PCa cells into androgen-independent manner and the potential mechanism.
Results
MSCs promote the growth of LNCaP prostate cancer cells in androgen-independent condition in vivo and in vitro. Firstly, we demonstrated that the development of LNCaP cells in male nude mice was significantly faster than in castrated nude mice. However, when LNCaP cells were coinjected with MSCs in castrated nude mice, the volume of tumor is higher than group injected with LNCaP cells alone (Fig. 1A,B) . Besides that, we also collected conditioned medium from MSCs. The conditioned medium was used to pretreat LNCaP cells. Then the pretreated LNCaP cells were implanted not only in male nude mice but also in castrated nude mice. As shown in Fig. 1C , no difference could be observed between the LNCaP cells that pretreated or unpretreated with conditioned medium when they were implanted in male nude mice. However, compared with control groups, a higher development of the tumor in castrated nude mice could be observed in the conditioned medium pretreated group (Fig. 1D) .
Furthermore, the effect of conditioned medium from MSCs was also confirmed by the proliferation and apoptosis of LNCaP cells in androgen deprivation (AD) condition. As shown in Fig. 2 , androgen deprivation significantly leaded to the proliferation inhibition and apoptosis enhancement in LNCaP cells. However, when LNCaP cells were treated with conditioned medium from MSCs, their growth showed an androgen-independent manner and the apoptosis decreased.
SSEA-4 has been reported as an effective marker to identify MSCs in tumor tissues 17, 18 , so we employed SSEA-4 to explore the presence of MSCs in tumors from castrated male nude mice injected with LNCaP cells alone or together with MSCs by immunohistochemistry (IHC). Obviously, compared with the tumors injected with LNCaP cells alone, high expression of SSEA-4 was detected in the stroma of tumors cojected with LNCaP cells and MSCs. MSCs were randomly distributed inside the tumor and the number was relatively high (Fig. 1E,F) . These results indicated that MSCs might play a potential role in inducing the growth of LNCaP cells from androgen-dependent into independent manner.
MSCs promoted the transformation of LNCaP cells via TGF-β.
Androgen receptor (AR) is a nuclear receptor that has been recognized as a major factor involved in prostate tumor genesis 19 . It also has been reported that IL-6, TGF-β and IGF-1 played an important role in activating AR 20, 21 . So we examined the expression of IL-6, TGF-β and IGF-1 in MSCs. The results showed that a substantial expression of TGF-β could be detected not only in MSCs but also in the conditioned medium (Fig. 3A,B) . However, we did not observe a spontaneously high expression of IL-6 and IGF-1 either in MSCs nor in the conditioned medium of MSCs (Fig. 3A,C,D) . The results indicated that the transforming effect of MSCs on LNCaP cells from androgen-dependent into independent manner might be mediated by TGF-β .
In order to confirm the function of TGF-β , we used shRNA to inhibit the expression of TGF-β in MSCs. Then function of MSCs si-TGF-β in inducing the transformation of LNCaP cells was examined in vivo and in vitro. As shown in Fig. 4A , MSCs si-TGF-β failed to promote the growth of LNCaP cells when they were coinjected in castrated nude mice. At the same time, LNCaP cells pretreated with conditioned medium collected from MSCs si-TGF-β did not exhibit a higher development speed than control group (Fig. 4B ). Besides that, in androgen retreatment condition, conditioned medium obtained from MSCs si-TGF-β could not lead to an androgen-independent manner in LNCaP cells (Fig. 4C,D) . Taken together, the results indicated that MSCs might induce the transformation of LNCaP cells from androgen-dependent into independent manner by producing TGF-β .
Androgen could effectively inhibite the expression of TGF-β in MSCs. The transformation of human PCa cells from androgen-dependent into independent manner always happens during the treatment of androgen blocking therapy. So we examined the effect of androgen on the expression of TGF-β in MSCs. Interestingly, the result showed that androgen could effectively inhibit the expression of TGF-β in MSCs (Fig. 5A ). As shown in Furthermore, once we removed the FBS from the culture medium of MSCs, this medium could lead to an androgen-independent manner in LNCaP cells (Fig. 5B,C) . These results illustrated that androgen blocking therapy that used in PCa treatment may induce a substantial expression of TGF-β in MSCs which leaded to the androgen-independent manner in human PCa cells. Correlations of MSCs with pathologic characteristics of PCa. We also employed SSEA-4 to explore MSCs in PCa tissues by immunohistochemistry (IHC). As shown in Fig. 6A , all 99 PCa patients were divided into two groups: the high expression group (n = 77) and low expression group (n = 22). High expression of SSEA-4 was detected in 77.8% of PCa tissues (77/99). The SSEA-4 expression level was found to be significantly higher in PCa patients with pathological stage (P = 0.026), lymph node status (P = 0.012), tumour margins (P = 0.049), gleason score (P = 0.007), and biochemical recurrence (P = 0.026) ( Table 1) MSCs known as multipotent stromal precursors display inherent tropism for tumor tissue 13 . Their function in tumors has led to a great deal of interest over the past decade. It has been reported that MSCs could differentiate into various specialized cell types under certain physiological or experimental conditions 7, 8, 23 and they have been recognized to contribute to the regeneration of a wide variety of organs and healing of some diseases [24] [25] [26] . Furthermore, MSCs also play an important role in treating various degenerative diseases and immune disorders. Therefore, MSCs have been regarded as a potential therapy for many diseases. Previous studies have shown that MSCs interact with tumor cells in a myriad of ways, which have the potential to support tumor growth, including promoting tumor vessel formation 26 , inducing immunosuppressive effect 27 , and constructing cancer stem cell niches 28, 29 . In order to clarify the utility of MSCs and avoid inappropriate use of MSCs in clinical therapy, we must fully understand the role of MSCs in malignant tumor, such as prostate cancer. Our results demonstrated that MSCs could affect the transformation of androgen-dependent human PCa cells into androgen-independent manner in vivo and in vitro. We know that androgen deprivation therapy is an important method for the clinical treatment of prostate cancer. However the transformation of human prostate cancer from an androgen-dependent manner to an androgen-independent manner is a lethal progression in clinical patients. It is the main obstacle that impacts the treatment during androgen deprivation therapy. Our results indicate that MSCs may support the growth of prostate cancer cells in androgen deprivation therapy, which will lead to androgen resistance in human prostate cancer cells. As we all know, TGF-β is a key cytokine, which is related to the tumor cell invasion and migration by regulating some cytokines expression in various tumor models. We found a substantial expression of TGF-β in MSCs in androgen deprivation condition, while there was no obvious expression of IL-6 and IGF-1 in MSCs at the same condition. Blocking the effect of TGF-β by siRNA could significantly inhibit the promotive function of MSCs in PCa cells. Besides that, our results also indicated androgen might inhibit the expression of TGF-β in MSCs. On one hand, MSCs might induce the transformation of LNCaP cells from androgen-dependent into independent manner by producing TGF-β . On the other hand, androgen blocking therapy that used in PCa treatment may induce a substantial expression of Furthermore, we employed SSEA-4 as a surface marker to identify MSCs in mice subcutaneous tumor models and clinical PCa tissues. The results illustrated that SSEA-4 positive MSCs were detected in PCa tissues and tumors cojected with LNCaP cells and MSCs in castrated nude mice. Furthermore,we also found that overexpression of SSEA-4 was significantly correlated with poor prognosis of PCaAnd the number of MSCs in PCa tissues was also associated with a worse overall survival (OS).
In conclusion, this study investigates the relationship among MSCs, prostate cancer cells, TGF-β and androgen. The results suggest that androgen blockade treatment in clinical PCa therapy may elicite the expression of TGF-β in MSCs, which will result in the transformation of androgen-dependent human PCa cells into androgen-independent manner. We expect that our findings will offer insights into further explore on the mechanism of prostate cancer development and provide a theoretical basis for finding new therapies for prostate cancer.
Materials and Methods
Cells and Animals. MSCs from the iliac crest bone marrow of multiple normal adult volunteers were isolated and cultured as described elsewhere 30, 31 . Cells were cultured in MSCs basal medium (Invitrogen,Carlsbad, CA). To confirm stem cell isolation, all bone marrow-derived cells were tested for their multilineage capacity using standard differentiation assays 32, 33 . Human PCa cell line LNCaP cells were purchased from the Cell Bank of Type Culture Collection of Chinese Academy of Sciences, Shanghai Institute of Cell Biology, Chinese Academy of Sciences and were cultured in RPMI1640 supplemented with 10% fetal bovine serum, streptomycin (0.1 mg/mL), penicillin (100 units/mL), and 250 nmol/L of dexamethasone at 37 °C in a 5% CO 2 atmosphere. Nude mice, 6-8 weeks old, were purchased from Shanghai Experimental Animal Center of the Chinese Academy of Sciences, Shanghai, China. Mice in this study were housed in pathogen-free conditions. All animal experiments were approved by the guidelines of the Animal Care and Experimentation Committee of Affiliated Tumor Hospital of Guangxi Medical University, and in accordance with the guidelines of Affiliated Tumor Hospital of Guangxi Medical University.
LNCaP murine prostate cancer model. LNCaP The Conditioned Medium (CM). MSCs were cultured with DMEM culture medium without FBS.
After continuous culture for further 12 h and 24 h, the conditioned medium was collected from the supernatant media of MSCs using 0.22 μ m filtration.
Real-time PCR. The total cellular mRNA was collected with Trizol Reagent (Invitrogen). cDNA was synthesized using MMLV reverse transcriptase(Promega) and 2 μ g total RNA and oligo dT18-primers. Two-microliter aliquots of cDNA were used for PCR amplification. Real-time PCR was performed in triplicate using the SYBR PrimeScript RT-PCR Kit (Takara). Primers for TGF-β mRNA determination were: 5′ -GCC GAG CCC TGG ACA CCA AC-3′ (forward) and 5′ -GCG CCC GGG TTA TGC TGG TT-3′ (reverse). Total sample RNA was normalized to endogenous β -actin mRNA. Thermocycler conditions included an initial hold at 50 °C for 2 minutes and then 95 °C for 10 minutes; this was followed by a two-step PCR program of 95 °C for 15 seconds and 60 °C for 60 seconds repeated for 40 cycles on an Mx4000 system (Stratagene, La Jolla, CA), on which data were collected and quantitatively analyzed. Expression level of mRNA was presented as fold change relative to an untreated control.
Enzyme linked immunosorbent assay (ELISA).
ELISA assays were performed with a commercial ELISA kit (R&D Systems, Minneapolis, MN). The MSCs conditioned medium was collected for further experiment. Assays were performed in duplicate, and readings were compared with standard curves Short interfering RNA (siRNA) synthesis and transient transfection. Three siRNA sequences of TGF-β were designed using Oligoengine software and verified by nucleotide BLAST searches. Three candidate sequences and a control sequence with no significant homology were listed in Table 2 . Cells (1-3 × 10 6 ) growing to 50-60% confluence in 10 cm petri dishes were transfected with siRNA sequences or their corresponding mock sequences using a Lipofectamine 2000 kit (Invitrogen, Cat.11668-019) with the procedure provided by the manufacturer. Cells were observed under a fluorescence microscope and harvested 48 h after transfection.
Immunohistochemistry staining. Tumor tissue sections (4 μ m thick) were cut and mounted on 3-aminopropyl-triethoxy-silane-coated slides. Incubation with monoclonal anti-human SSEA-4 antibody (eBioscience) was performed at room temperature for 1 h, after blocking endogenous peroxidase activity. Detection of the primary antibody was performed using rabbit anti-mouse antibody (DAKO A/S, Denmark) and streptavidin-biotin-horseradish peroxidase complex (SABC/HRP, DAKO A/S, Denmark). Table 2 . Sequence of the oligonucleotides for siRNA construct-making assays.
